Friday, Sep 17, 2021 | Last Update : 12:39 AM IST

  Business   Companies  15 Jul 2020  Zydus begins human trials for potential COVID-19 vaccine

Zydus begins human trials for potential COVID-19 vaccine

REUTERS
Published : Jul 15, 2020, 10:34 am IST
Updated : Jul 15, 2020, 10:34 am IST

In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India

 Indian pharmaceutical company Zydus started human studies for its potential COVID-19 vaccine. (AP Photo)
  Indian pharmaceutical company Zydus started human studies for its potential COVID-19 vaccine. (AP Photo)

BENGALURU: Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential COVID-19 vaccine, as coronavirus infections continue to surge in the world’s third worst-hit nation.

ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies, Zydus said.

 

In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India.

Tags: india, pharmaceuticals, zydus, covid-19 vaccine, coronavirus
Location: India, Karnataka, Bengaluru